The findings in the current study suggest that aspirin may be effective during the pregnancy of ET patients, especially when the JAK2 (V617F) mutation is present. However, the use of aspirin in pregnancy deserves further investigation in a prospective trial

Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies

PASSAMONTI, FRANCESCO;
2009-01-01

Abstract

The findings in the current study suggest that aspirin may be effective during the pregnancy of ET patients, especially when the JAK2 (V617F) mutation is present. However, the use of aspirin in pregnancy deserves further investigation in a prospective trial
2009
http://www.ncbi.nlm.nih.gov/pubmed/19912517
ASPIRIN; PREGNANCY; ESSENTIAL THROMBOCYTHEMIA
Passamonti, Francesco; Rumi, E.; Randi, M. L.; Morra, E.; Cazzola, M.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2023224
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 25
social impact